GlassScriptPhysician profile
Amanda Riggins
NPI 1831783000
$3,951.36
in general payments reported to CMS, 2019-2025
37 companies · $578 in 2025
The $578 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $638 · 2023: $1,289 · 2024: $1,447 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,211 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,211.20 |
| Education | $102.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $643.15 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $470.98 | 2022-2025 | Breztri, Fasenra, Airsupra |
| Alexion Pharmaceuticals, INC. | $274.40 | 2023-2024 | Ultomiris, Soliris |
| Neurocrine Biosciences, INC. | $220.52 | 2023-2025 | Ingrezza |
| Actelion Pharmaceuticals US, INC. | $213.12 | 2022-2025 | Uptravi, Opsumit |
| Csl Behring | $202.62 | 2022-2025 | Hizentra |
| Axsome Therapeutics, INC. | $163.56 | 2023-2025 | Sunosi |
| Baxter Healthcare | $149.40 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Pfizer INC. | $130.49 | 2023-2024 | |
| Harmony Biosciences LLC | $128.06 | 2023-2025 | Wakix |
| Grifols USA, LLC | $127.71 | 2022-2024 | Prolastin-C Liquid |
| Electromed, INC. | $116.79 | 2023-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $116.57 | 2022-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.39 | 2022-2023 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Emd Serono, INC. | $101.90 | 2022-2025 | Mavenclad |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $99.76 | 2022-2025 | |
| Lundbeck LLC | $86.40 | 2022-2024 | Vyepti |
| Genzyme Corporation | $79.30 | 2023-2024 | |
| Insmed, INC. | $76.99 | 2022 | |
| Pulmonx Corporation | $52.90 | 2023 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Mylan Specialty L.P. | $48.93 | 2022 | |
| Mallinckrodt Hospital Products INC. | $47.62 | 2022-2024 | Acthar |
| Merck Sharp & Dohme LLC | $34.53 | 2024 | Keytruda, Dificid, Zerbaxa |
| Biogen, INC. | $33.24 | 2023-2024 | Tysabri, Vumerity |
| Takeda Pharmaceuticals U.S.A., INC. | $25.62 | 2025 | Hyqvia |
| Catalyst Pharmaceuticals, INC. | $24.61 | 2022 | |
| Amgen INC. | $20.72 | 2022 | |
| Supernus Pharmaceuticals, INC. | $18.82 | 2022 | |
| Inspire Medical Systems, INC. | $18.48 | 2023 | Inspire |
| Collegium Pharmaceutical, INC. | $16.73 | 2022 | |
| Gilead Sciences, INC. | $16.36 | 2022 | |
| Viatris Specialty LLC | $15.62 | 2025 | Yupelri |
| Neurelis, INC. | $15.52 | 2025 | Valtoco |
| Vanda Pharmaceuticals INC. | $14.80 | 2025 | Ponvory |
| Amneal Pharmaceuticals LLC | $14.73 | 2024 | Rytary |
| Verona Pharma, INC. | $14.05 | 2025 | Ohtuvayre |
| Kyowa Kirin, INC. | $13.97 | 2023 | Nourianz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Riggins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.